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Abstract
Background: Hepatitis C virus (HCV) is a blood-borne pathogen that can cause severe liver disease,
cancer, and death and is a significant source of morbidity and mortality in the United States. Several
academic medical centers including University of Kentucky Healthcare have implemented routine HCV
screening for patients presenting to the emergency department (ED) and have discovered a large viral
burden amongst patients who are often symptomatic.
Purpose: The purpose of this doctoral project is to increase staff compliance, confidence, and education
regarding the HCV screening process in an urban, Level I emergency department, as well as to evaluate
whether an attempt at increasing patient knowledge of hepatitis C through informative flyers in treatment
areas would increase linkage to care and successful follow-up rates after receiving a positive diagnosis.
Specific objectives include to 1) increase bedside nurse and ED provider compliance in ordering HCV
tests and communicating positive test results and follow-up care information to our patient population,
and to 2) disseminate educational materials to patients regarding HCV transmission and complications if
left untreated to increase linkage to care rates.
Methods: This project is a single-site, multimodal project designed to both examine the impact of an
education intervention via informal staff in-services using a pre- and post-survey as measurement, and to
utilize a secondary data analysis approach to compare linkage-to-care rates following distribution of
educational information to patients. The project examined cross-sectional survey responses obtained from
clinical staff in the ED, as well as tertiary data obtained from deidentified patient chart reviews.
Results: A total of 49 staff members completed the pre-survey and 48 staff members completed the postsurvey following 10 educational in-services. Statistically significant changes were observed in testing
compliance (p = .028) and reported feelings of confidence with HCV knowledge and testing/ diagnosis ( p
= .016). A relative increase in the number of patients tested was observed in Dec. 2021 and January 2022.
Conclusion: Knowledgeable and confident healthcare providers are vital for improving patient outcomes
and can be achieved through in-services. Future research should focus on continued staff education,
implementation of dedicated patient navigators, and tackling the barriers of successful follow-up.
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Introduction
Hepatitis C virus (HCV) is a blood-borne disease that causes inflammation and tissue
damage in the liver and affects more than 2.4 million people in the United States (CDC, 2018).
After adjusting for under-ascertainment and under-reporting, an estimated 50,300 cases of
hepatitis C occurred in 2018 alone (CDC, 2018). Oftentimes those infected with hepatitis C are
asymptomatic, and in turn do not seek treatment. Acute HCV, if left untreated, can develop into a
chronic disease state and lead to liver damage, cirrhosis, liver cancer, and death, and more than
half of persons who become infected with HCV will develop chronic infection (CDC, 2018). An
all-oral direct-acting antiviral (DAA) medication regimen can result in a virologic cure in most
persons in 8-12 weeks. Because HCV symptoms are often vague or absent, the Centers for
Disease Control and Prevention augmented testing guidelines to a universal model and now
recommend HCV testing for all adults aged ≥ 18 as well as all pregnant women during each
pregnancy (CDC, 2018). Because the emergency department provides care to a broad spectrum
of patients, a significant proportion of whom are deemed high-risk or socioeconomically
disadvantaged, an ED-based, routine hepatitis C screening program has been beneficial in the
diagnosis and treatment of HCV, especially with the development of newer curative therapies.
A routine hepatitis C screening program has been implemented at several urban
emergency departments across the United States in order to better determine HCV antibody and
viral load burden. These emergency departments have discovered a high prevalence of
undiagnosed HCV cases with a routine screening program and have demonstrated a beneficial
and cost-effective way to diagnose patients who would likely not be tested otherwise (Lyons et
al., 2016) (White et al., 2016). As of July 2020, the emergency department at University of
Kentucky HealthCare (UKHC) has tested over 50,000 patients for hepatitis C, revealing a 9.9%
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rate of positivity for the HCV antibody and a 46.1% rate of positivity during confirmatory
ribonucleic acid (RNA) testing (Moore, Korosec, Howard, 2020). Subsequent linkage to care
following routine HCV testing at UKHC has revealed several barriers to treatment that mimic
those defined in the literature from other screening programs, making the follow-up process
difficult and often unsuccessful. Our current linkage to care rate at UKHC is 44.5% (Moore,
Korosec, Howard, 2020). However, to date, of the 1,730 patients who have tested HCV RNA
positive, only 190 patients have initiated DAA therapy, with even fewer achieving a curative
sustained virologic response (Moore, Korosec, Howard, 2020). This leaves significant room for
improvement in the realms of both patient and provider education as well as follow-up and
linkage to care processes.

Background
Hepatitis C causes inflammation of the liver and can present as both an acute and chronic
infection. Acute HCV infections are usually asymptomatic, and most do not lead to a lifethreatening disease; approximately 30% of infected persons spontaneously clear the virus within
six months of infection (World Health Organization, 2021). However, the other 70% of persons
go on to develop a chronic hepatitis C infection, with a 15-30% risk of developing cirrhosis
within twenty years (World Health Organization, 2021). HCV is bloodborne and is most
commonly transmitted through the reuse or inadequate sterilization of syringes and needles by
injection drug users, from an infected mother to her baby, via unsafe sexual practices that lead to
blood exposure, and less commonly from the transfusion of unscreened blood and blood products
(World Health Organization, 2021). Cases of acute HCV infection have increased approximately
3.8-fold over the last decade because of increasing injection drug use and improved surveillance
(USPSTF, 2020).
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Symptoms of all types of viral hepatitis, including hepatitis A, B, and C are similar and
can include jaundice, fever, fatigue, loss of appetite, nausea, vomiting, abdominal pain, joint
pain, dark urine, and/ or clay-colored stool (CDC, 2020). The incubation period for hepatitis C
ranges from two weeks to six months, although approximately 80% of people never exhibit any
symptoms during this period (World Health Organization, 2021). Historically, HCV infection
has been described as a ‘silent epidemic’. For this reason, few people are diagnosed with HCV
when the infection is recent, and for the > 50% of those who develop chronic HCV infection,
symptoms often don’t present for decades until after serious liver damage has already occurred.
Hepatitis C is diagnosed in two separate steps; an initial anti-HCV antibody serologic test is
performed, and if this returns as a positive result, an HCV RNA test is utilized to confirm
chronic infection.
Because early diagnosis of hepatitis C can prevent serious liver damage and prevent
further transmission of the virus, the U.S. Preventive Services Task Force updated their
recommendations for testing to all adults aged 18 to 79 years (USPSTF, 2020). This is consistent
with CDC recommendations for testing all adults aged 18 and older at least once, as well as all
pregnant women during each pregnancy, people who currently inject drugs and share needles or
syringes, people who have ever injected drugs, people with HIV, people who receive
maintenance hemodialysis, people with persistently abnormal ALT levels, and prior recipients of
blood transfusions or organ transplants prior to 1987 (CDC, 2020).
While the entire United States has suffered from the opioid epidemic for several decades,
Kentucky has been particularly affected harshly by illicit fentanyl, methamphetamine, and heroin
use, with a 50% increase in drug overdose deaths in 2020 compared to the year prior according
to the Kentucky Justice & Public Safety Cabinet (Overdose Fatality Report, 2020). Nearly 2,000
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Kentuckians died in 2020 alone due to drug overdoses amid months of unprecedented lockdowns
and record unemployment (James, 2021). People who inject drugs, or PWIDs, are at particularly
high risk of contracting bloodborne infectious diseases like hepatitis C because of unsafe needle
practices. The rate of new hepatitis C cases reported to the CDC among persons aged 18-40
years has increased steadily each year since 2013 to 2.8 cases per 100,000 population in 2019
(CDC, 2021). Injection drug use is the most common risk reported for persons with new hepatitis
C virus infection, and increases in HCV incidence, particularly among persons aged 18-40 years,
are temporally associated with increases in this risk factor (CDC, 2021). Persons who inject
illicit drugs are the group most severely affected by the HCV epidemic, but often the least likely
to receive treatment. Among people aged 18-29, HCV increased by 400% and admission for
opioid injection by 622% (CDC, 2021). The Appalachian region, including areas of Kentucky,
West Virginia, Ohio, and Tennessee, is thought to be at extremely high risk for an infectious
outbreak of hepatitis C and HIV; these are all states within UK HealthCare’s catchment area,
with care provided to patients from these areas routinely. During the 2016 fiscal year, UK
Chandler and Good Samaritan emergency departments had a combined 2,247 opioid-related
visits and 44 opioid-related deaths, and by fiscal year 2019, those values had nearly doubled to
3,507 visits and 79 deaths, respectively.
A greater understanding of the hepatitis C genome has allowed scientists and drug
manufacturers to improve the efficacy and tolerability of HCV treatment with multiple directacting antiviral options. These revolutionary medications have transformed the management of
HCV and prompted the WHO to set the goal of viral elimination by 2030 (WHO, 2021). Because
the early detection of hepatitis C is significant in order to initiate timely treatment that decreases
the risk of liver damage and disease, several different screening strategies have been
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implemented at healthcare organizations worldwide. Some of these programs have focused
efforts for HCV screening on patients in the emergency department setting; the reasoning behind
this strategy is the over-representation of at-risk groups in this vulnerable population, including
PWID, immigrants, patients with dual-diagnosis conditions, the homeless, prisoners, etc. In
2018, the University of Kentucky joined other academic medical centers across the country by
implementing an emergency-department based routine hepatitis C screening program.

Literature Review
The evidence overwhelmingly supports both continued implementation of hepatitis C
screening in an emergency department setting while also supporting the unfortunate reality of
poor linkage to care and subsequent curative therapy post-HCV screening. Some studies reported
a successful linkage to care rate of upwards of 45% (Denniston, Klevens, McQuillan, & Jiles,
2012). However, it is not uncommon for an establishment to report successful follow-up rates of
20% or less (Anderson et. al, 2017) (Franco et al., 2016). A bottleneck effect was displayed in a
majority of studies that implemented ED HCV screening, where a significant number of patients
tested positive for HCV, a fewer amount were successfully notified of their diagnosis, and even
fewer attended at least one follow-up appointment or achieved a sustained virologic response, or
SVR (Anderson et. al, 2017) (Lier et al., 2019). One retrospective cohort study even coined this
bottleneck effect as the ‘No Show Phenomenon’ of hepatitis C care (Franco et al., 2016).
The University of Kentucky operates the highest volume emergency department-based
HCV screening and linkage to care program in the country and has screened over 65,000 patients
for HCV since the program began in 2018 (Moore, 2021). Within the first six months of
UKHC’s ED-based HCV screening program, 1,459 patients had a positive HCV antibody; 43%
of those patients admitted a prior history of IV drug use, and 70% of them were born after 1965.
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As of July 2020, UKHC had a 9.9% HCV antibody positive rate, with 46.1% of those patients
receiving a confirmatory RNA result. At that time, 44.5% of patients were linked to care. Results
in 2021 were similar to that of previous years, with an average HCV antibody positive rate of
8.2%, a confirmatory RNA positive rate of 48.2%. Only 46% of patients were linked to care.
A large proportion of participants are attending at least one follow-up appointment but
are not advancing to treatment for a variety of reasons. Several well-defined barriers to HCV
follow-up care and treatment exist in the literature. These barriers include stigma, lack of social
support, complex treatment regimens, language barriers, and ability to pay (Sublette, Smith,
George, McCaffery, & Douglas, 2015). A more detailed examination of the barriers slowing or
preventing the progression of HCV treatment revealed that self-reported illicit drug use within
the past six months was a significant barrier to treatment (Falade-Nwulia et al., 2019). Other
significant barriers included having no insurance and being a white male (Franco et al., 2016).
On the opposite hand, identifiable facilitators to successful linkage to care included
patients with a prior diagnosed history of cirrhosis and having access to primary care (Franco et
al., 2016). Patients with a coinciding HIV infection for which they were already receiving
treatment were also more likely to follow up outpatient (Falade-Nwulia et al., 2019). Although
the University of Kentucky has successfully linked 57% of RNA+ patients to care, our institution
has only initiated curative therapy in 278 of the 876 patients identified in the UKHC clinic
(Moore, 2021). While this is a step forward in preventing severe downstream morbidity and
mortality, there is still much room for improvement.
The focus of recent literature has shifted from accumulating evidence to support routine
ED-based HCV screening programs to discovering innovative and efficient ways to improve
linkage to care for patients to assist them in initiating DAA therapy and achieving an SVR. In
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one study conducted at a large medical center in Tel-Aviv, of the 17 patients found to be HCV
positive, only three patients expressed interest in treatment during initial phone conversations but
never arrived for clinic appointments, and no patients actually received DAA treatment at the
end of follow-up (Houri, Horowitz, Katchman, Weksler, Miller, Deutsch, & Shibolet, 2020).
This lack of follow-up was attributed to a majority of those patients who were homeless or
admitted to using illicit drugs and not having a reliable contact method upon discharge (Houri et
al., 2020). At another academic tertiary care emergency department, a non-targeted, opt-out
HCV and linkage to care program was implemented, and of the 3.1% of patients who had HCV
on confirmatory RNA testing, only 21% were linked to care (Blackwell, Rodgers, Franco,
Cofield, Walter, Galbraith, & Hess, 2020).
In-service training of nurses and other healthcare providers plays an indispensable role in
improving the quality of patient care, and staff education is crucial for achieving organizational
goals (Chaghari, Saffari, Ebadi, & Ameryoun, 2017). In-service training provides an avenue for
promoting both the empowerment and competency of employees for the better understanding
and completion of specific tasks; in the healthcare realm, this often results in improved patient
outcomes and care delivery models. When nurses and providers feel confident in the policies and
procedures regarding standards of care, patients will receive refined, transformative care.

Purpose
The purpose of this DNP project was to increase ED nursing and provider knowledge and
compliance regarding the routine HCV testing program at UK HealthCare, and to evaluate
current follow-up and linkage to care processes for patients testing positive for hepatitis C. The
project was completed utilizing both a descriptive, non-randomized design for evaluation, as well
as a secondary data analysis. Specifically, this project aimed to examine staff knowledge
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surrounding the ED-based HCV testing program before and after an educational intervention
provided to nurses and providers, and to examine follow-up and linkage to care rates before and
after placing informational flyers across the department for patients to read during wait periods.
The project emphasized staff and patient education to allow nurses and providers to feel
confident when testing and relaying results to patients, with the eventual goal of increasing the
number of patients attending follow-up appointments and initiating direct-acting antiviral
therapy. Understanding staff perception of baseline knowledge and daily workflow processes
regarding hepatitis C testing can create an avenue for providing effective educational in-services
and reinforcing best-practice scenarios and standards of care.
The specific aims of this project were to:
1. Improve both nursing staff and provider compliance with hepatitis C screening and inperson diagnosis and dissemination of follow-up information by holding several informal inservices during pre-shift huddles.
2. Increase patient education regarding the HCV testing and treatment program via
dissemination of patient education information in the ED setting, with the eventual goal of
increasing patient awareness and inclination to follow up on positive hepatitis C results in the
outpatient setting.

Theoretical Framework
The conceptual framework utilized for this DNP project was constructed from Andreas
Faludi’s Comprehensive Rational Planning Model, a model of the planning process involving
several rational actions or steps (Faludi, 1986). The modern CRP theory model gained ground in
the 1950s and 60s and is one of the major streams in planning theory. Faludi argues that planning
is a decision-making process that should be rational by comprehensively evaluating all possible
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actions considering their respective consequences (Faludi, 1986). This model focuses on the
steps or activities in selecting alternatives, including defining the problem, listing goals and
objectives and their relative values, identifying the alternative that maximizes attainment of goals
and objectives, and implementing those alternatives (Faludi, 1986). Results are monitored in a
feedback loop-type system where results are utilized to formulate or change new objectives and
targets. This approach also considers peripheral influences during the planning process and how
they may affect the program (Issel, 2004). Utilizing this model, an ED staff education and
training program could be implemented in order to increase nurse and provider familiarity,
knowledge, and confidence in the hepatitis C screening program and eventually increase followup rates in the outpatient setting.

Methods
Design
This project utilized both a descriptive, non-randomized design with an electronic survey
as well as a secondary data analysis. A pre- and post-survey related to HCV screening
procedures and follow-up situated in Qualtrics was sent via an electronic, unit-based listserv to
clinical staff members in the ED (see Appendix G). After pre-survey data was collected, eight
educational in-services lasting approximately 5-10 minutes were held during pre-shift huddles
for nursing staff and handoff exchanges for provider staff. A ‘Get Tested, Get Treated’
educational flyer was placed in patient care areas, including the ED lobby, patient restrooms,
triage areas, and treatment rooms as a reminder to patients that they would receive HCV testing
as a part of standard care in the ED (see Figures 1, 2). Following these educational interventions,
a secondary data analysis was conducted in the form of a chart review from an existing medical
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record data set of patients testing positive for HCV to determine if a change in testing rates and/
or follow-up rates was observed, and to what extent.
Setting
This project was conducted at the University of Kentucky Emergency Department
(UKED), a Level I Trauma Center located in central Kentucky. The UKED is a newly
constructed, 40,000-square foot facility equipped with state-of-the-art medical equipment. The
UKED serves both pediatric and adult patients with approximately 85,000 visits annually and an
average of 225 patients every day, although these values were much higher prior to the COVID19 pandemic. Between Chandler and UK Good Samaritan Hospital, UK HealthCare is the
busiest emergency department in the state and among the top 25% in the country. The ED
utilizes approximately 120 treatment spaces and comprises three separate areas, including the
Makenna David Pediatric Emergency Center, the Level I Trauma Center, and the Adult
Emergency Center with an ‘express care’ area for less acute, non-urgent conditions.
UK HealthCare is committed to creating a healthier Kentucky by improving care delivery
assessments to continue being a high reliability, high-value organization, and by empowering
UK HealthCare staff to create a patient-centered environment where patients feel valued and
respected so that they are confident in their care and engage with healthcare providers to focus
on their health (UK HealthCare, 2021). This healthcare organization operates under five values
that help guide actions, behaviors, and decision-making, including diversity, innovation, respect,
compassion, and teamwork (UK HealthCare, 2021). This DNP project encompassed the mission,
vision, and value of UK HealthCare’s 2025 Strategic Plan by seeking to improve the health of
the patients we serve and by empowering emergency department staff to provide evidence-based,
innovative care delivery models to ED patients.
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Sample
Approval for this DNP project was obtained from the University of Kentucky
Institutional Review Board (IRB) as well as the University of Kentucky Nursing Research
Council (NRC) prior to the initiation of the project. After receiving IRB and NRC approval, an
email invitation to participate in the project with an enclosed cover letter was distributed via an
electronic unit-based listserv to approximately 170 nursing staff members and 60 ED providers,
including resident physicians, attending physicians, and advanced practice providers. The email
included a secure link to a Qualtrics pre- and post-survey. All subjects were >18 years of age,
employed by Emergency Medicine or Emergency Services and provided care to those adult
patients who received routine hepatitis C screening as part of standard care in the ED. A
secondary study population is a chart review on those adult patients who were screened for
hepatitis C in the ED and were HCV positive. Inclusion criteria included: female and male
nurses, advanced practice providers (physician assistants and nurse practitioners), resident
physicians, and attending physicians on day, mid, and night shifts in the ED, as well as all
patients testing positive for hepatitis C via ED screening. Exclusion criteria included: anyone less
than 18 years of age, ED ancillary staff, nursing care technicians, or any staff member not
willing to complete an online, anonymous survey.
Data Collection
ED staff members, including nurses and providers, were sent an email that included a
cover letter entailing details of the study, including study purpose, risks/ benefits, study
objectives, principal investigator (PI) contact information, and UK College of Nursing contact
information. If participants were agreeable, a survey link within the same email was embedded
and participants were taken to a secure Qualtrics survey site. This survey was completely
anonymous and could not be traced back to any one employee; it was also voluntary and not a
16

condition of employment. Permission was received from ED leadership to send the surveys, hold
educational in-services, and perform a retrospective chart review.
A de-identified chart review was also performed for patients testing positive for hepatitis
C and included data points such as number of unique patients screened, HCV antibody results
both positive and negative, RNA results received both positive and negative, and linkage to care
rate. Because both the pre- and post-surveys as well as the secondary chart review were
anonymous and de-identified, A “Waiver of Documentation of Informed Consent” and Form K
“Waiver of HIPAA Documentation” were submitted and approved by the University of
Kentucky IRB and Office of Research Integrity (ORI).
Data Analysis
Two datasets were generated from the exported Qualtrics data and descriptive statistics,
including means, standard deviations, and frequency distributions were utilized to summarize
study variables. HCV testing rates and linkage to care rates were compared before and after
educational in-services for ED staff were held. All data analysis was conducted utilizing SPSS
version 26 with an alpha of .05 to determine statistical significance. A 95% confidence level was
utilized for all statistical analysis. Content analysis of qualitative free-text responses was
completed by identifying key themes regarding the HCV testing program. Confidence levels and
HCV knowledge items were compared pre- and post-education using the Pearson chi-square tests
of association and independent samples tests.
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Results
Sample Characteristics
A total of 49 surveys were completed pre-educational in-services and 48 completed postintervention. The majority of participants identified as registered nurses, compiling 63.3% of the
pre-education responses and 43.8% of the post-education responses. Response rates were then
led by attending physicians (20.4% pre-education, 31.3% post-education), advanced practice
providers (10.2% pre-education, 16.8% post-education), and finally by resident physicians (6.1%
pre-education, 8.3% post-education). Age, gender, or years of experience were not factored into
this study. See Table 1 for results.
A total of 28,914 patients were screened for hepatitis C from October 2021 through
March 12, 2022. 607 patients had a positive hepatitis C antibody, and 289 (47%) of those
patients had a confirmatory RNA positive test.
Hepatitis C Testing Trends
When asked what their next action is following the hard stop ‘Best Practice Advisory’
notification on the electronic health record, the majority of participants (36%) stated that they
ordered the test and did not inform the patient of the screening program prior to the educational
in-service. Following staff education, 45% of participants chose this response. There was also a
decrease observed in the number of participants who reported ‘skipping’ or ‘never ordering’ the
test from 14% to 10% post-education. These responses among others are illustrated in Figure 4.
Following the educational sessions, testing compliance increased significantly with a pvalue of 0.028 (see Table 3). Prior to the staff education sessions, 58% of participants responded
that they ‘sometimes or always order the HCV test’; that value increased to 79% of participants
following education.
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Staff Confidence Characteristics
When asked to rate their confidence in telling a patient that they were tested for hepatitis
C, a statistically significant change was observed following in-service education with a p-value
of 0.016 (Table 2). While 32.7% of respondents reported feeling ‘not confident’ or ‘somewhat
confident’ before the education, this value decreased to 12.5% after the education (Table 2).
46.9% of respondents reported feeling ‘fairly confident’ or ‘very confident’ prior to educational
in-services, while 56.3% of participants reported this confidence following the education.
Staff Knowledge
The knowledge questions regarding HCV testing and linkage to care trends were
statistically analyzed for the number of correct answers from participants. The pretest (n = 48)
had a mean (SD) of 1.44 (0.85), and the posttest (n = 47) had a mean (SD) of 1.77 (0.81) (Table
2). Between the mean number of knowledge questions answered correctly between the pre- and
posttest, there was technically not a statistically significant difference as evidenced by a p-value
of 0.057.
Key Themes
During the post-educational in-service phase, an additional question was added to the
survey opening the floor to respondents for suggestions and/ or feedback related to the testing
program and DNP project. This allowed respondents to include more information and to express
their true feelings and attitudes regarding the program. Twelve respondents included feedback,
and some themes identified in their responses are as follows:
-

Making the tests automated or part of the triage navigator in EPIC (EHR)

-

Unawareness of the existence of the follow-up packet for HCV+ patients before the
project implementation
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-

Uncomfortable with/ unaware of the process of HCV screening before the project
implementation

HCV Testing & Linkage to Care Trends
As illustrated in Table 4, hepatitis C testing rates, antibody/ RNA positive results, and
linkage to care rates were observed via a de-identified chart review beginning in October 2021
and lasting until the conclusion of this DNP project in March 2022. In November 2021, we had
a 45.1% linkage to care rate, which was much greater than the surrounding months and was
observed during the time that educational flyers were being posted around the department. We
also observed a relative increase in testing rates in December and January during the time in
which staff in-services were being held. Unfortunately, the months of December 2021 through
February 2022 were defined by relatively lower linkage to care rates than the previous months.
Of note, only twelve days of data was available for March 2022 due to the conclusion of this
project.

Discussion
The overarching goal of this DNP project was to examine the current state of practice and
staff-driven protocols associated with hepatitis C screening and linkage to care and to gauge the
influence of a two-fold educational intervention on testing compliance in the emergency
department and follow-up rates in the outpatient setting. As described in the literature, in-service
training of nurses plays an indispensable role in improving the quality of patient care and
improving nursing performance (Chaghari et al., 2017). Previously conducted educational inservices have led to improved provider knowledge and attitudes regarding the specific topic. The
assessment and interventions aimed at improving compliance, confidence, and linkage to care are
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pivotal in ensuring the continued success of the HCV screening program and refinement of
linkage to care for patients.
Because HCV testing is currently considered a standard care procedure in the ED setting,
staff members should ideally be ordering the HCV serum test and only informing the patient of
the test when prompted. Although not statistically significant, the improvement from 36% to
45% of participants choosing this response supports the idea for continued staff education, as
does the statistically relevant increase in testing compliance from 58% to 79%. A non-significant
decrease in the number of respondents who ‘skip’ or ‘never order’ the test from 14% to 10% was
likely also a positive consequence of staff members being educated on the relationship between
the opioid epidemic in Kentucky and our subsequent rise in HCV diagnoses.
Following the educational sessions, hepatitis C testing compliance increased significantly
with a p-value of 0.028. Prior to the in-services, 58% of participants responded that they
‘sometimes or always order the HCV test’, a value that increased to 79% following staff
education. The number of participants that reported non-compliance with ordering tests
decreased by > 50% following education. Although not statistically significant, an increase in
knowledge regarding hepatitis C curability and diagnosis rates was observed at the completion of
data collection.
Staff education may also have had a direct impact on reported feelings of confidence with
hepatitis C testing and treatment knowledge. When asked to rate their confidence, a statistically
significant change was observed following in-service education with a p-value of 0.016. More
respondents reported feeling ‘fairly confident’ or ‘very confident’ following the in-services
which was a > 10% increase than previously reported.
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The open-ended survey responses provided extremely valuable information and allowed
ED staff members to vocalize their true opinions and beliefs and to express any concerns or
suggestions that they may have had throughout completion of this project. The key themes
identified in the survey supported the idea of staff education, as several people expressed no
prior knowledge of the program or the informational packets that should be given to every
patient that tests HCV+ prior to leaving the department.
Although no statistically significant changes were observed in HCV testing rates and
linkage to care trends, a 45.1% linkage to care rate was observed for the month of November.
This value was greater than the two months preceding and four months following. Unfortunately,
decreased linkage to care rates during the months of December 2021- February 2022. This was
likely related to the holiday season or to weather-related complications during the winter months.

Implications for Future Research
This project suggested that an educational intervention can increase confidence and
compliance with a staff-driven HCV screening protocol in the emergency department setting.
This increase in compliance may have had a direct influence on the number of patients being
screened during their ED visit, as well as the number following up in the outpatient setting.
Currently, ED-specific Licensed Clinical Social Workers (LCSWs) at UKHC are
responsible for contacting patients to notify them of their hepatitis C infection if they are not
made aware of this diagnosis prior to discharge from the hospital. Because the barriers to linkage
to care at UK HealthCare are well-defined and mimic those of the literature, implementing
dedicated patient navigators may be a focal point for future research. Patient navigators could be
solely responsible for linkage to care of persons testing HCV+ and can build a rapport with
patients to assist them in feeling at ease throughout the linkage to care and treatment initiation
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phase. An additional change to current protocols could be the implementation of HIPAAprotected text messaging as opposed to phone calls to contact patients, as this has been suggested
in the literature as a successful strategy for younger, hard-to-reach patients (Collins, Armenta,
Cuevas-Mota, Liu, Strathdee, & Garfein, 2016). The implementation of a privacy protected text
messaging system could potentially have a positive influence on the ‘No-Show Phenomenon’
gap in care that was highlighted previously.
Perhaps one of the most crucial implications for future research is the profit margin that
UK HealthCare could potentially see with continued implementation of the HCV screening
program. Fiscal Year 2022-2025 could bring up to an additional $92.4 million of drug margin to
UKHC from the prescriptions associated with a predicted 6,500 RNA+, treatment-eligible
patients (Moore, 2021).

Limitations
Unfortunately, several limitations presented themselves throughout the completion of this
DNP project. Despite a decent response rate of almost 50, this relative value represented a mere
⅓ of eligible ED staff members who completed the pre- and post-surveys. This is probably a
result of the phenomenon of ‘survey fatigue’, where respondents become bored or apathetic of
the survey process. The survey process was also anonymous, making data analysis difficult when
trying to determine if the same staff members took both the pre- and post-education
surveys. Additionally, three surveys were discarded due to incompletion.
Another limitation of this study was the inability to impact patients in the outpatient
setting, as this secondary data analysis was de-identified and no patient identifiers were
available. Several of the barriers to linkage to care that have been previously defined and mimic
those of patients at UK HealthCare, including homelessness, inability to pay, stigma, and lack of
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support are all influential factors that could be addressed with our patient population in order to
increase initiation and compliance with DAA treatment.
The final limitation of this study was the strategy of holding in-services during pre-shift
huddles or during times of patient exchange for providers. Although this is the most realistic
opportunity to reach the maximum amount of ED staff members at one time, these huddles are
often extremely busy and sometimes unorganized, making dissemination of educational
materials complicated.

Conclusion
Hepatitis C rates continue to rise at an alarming rate among young adults and millennials,
especially in the Appalachian regions of Kentucky, Tennessee, Virginia, and West Virginia,
where rates have more than tripled in the last decade. People who inject drugs represent the
majority of these new diagnoses and also represent a large demographic of the University of
Kentucky emergency department. Hepatitis C screening in the ED setting is a crucial public
health service that can not only identify patients who are unknowingly infected with a curable
disease known to have progressive consequences if not treated but can also link those patients to
an abundance of resources, including pharmacists, GI specialists, infectious disease providers,
social work, and care coordinators.
This DNP project ultimately fulfilled the aim of improving nursing staff and provider
education, confidence, and compliance with hepatitis C screening and may have had a positive
influence on the number of patients following up in the outpatient setting. This project suggested
that a non-targeted HCV screening program can potentially be optimized through continued
patient and provider education. ED staff members should continue to work collaboratively to
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implement effective educational tools and resources to ensure the continued success of the
program and improved health of our patient population.
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Appendix G: Survey Tool
Q1. When the Best Practice Advisory below appears, what is typically your next action? Select all that apply to your specific
workflow:

-

I order both tests & do not inform the patient that they will be tested
I order both tests after I inform the patient of the routine screening program (given they provide consent)
I ask the patient if they’ve had a negative HCV test within the last year before ordering
I sometimes order the test depending on the patient’s chief complaint
If I feel too busy, I will skip the test to lessen my workload
I never order the test

Q2. How confident are you when telling a patient that they will be tested for hepatitis C as a routine screening procedure?
Not confident
Somewhat confident
Fairly confident
Very confident
I don’t tell the patient
Q3. How important do you think it is to screen our specific patient population for hepatitis C?
Not important
Somewhat important
Very important
Q4. Do you feel like ordering and completing HCV testing disrupts your workflow?
Yes
Sometimes
No
I never do this
Q5. Do you order and complete the HCV test on EVERY patient?
Yes
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-

Sometimes
No

Q6. How often do you skip HCV testing?
Always
Often
Sometimes
Rarely
Never
Q7. How often have you observed your patients be given the hepatitis C follow-up informational packet when they have tested
positive?
Always
Often
Sometimes
Rarely
Never
Q8. Do you feel comfortable relaying positive hepatitis C test results to a patient and distributing resource packets?
Yes, I feel comfortable
No, I don’t feel comfortable
I don’t tell the patient
Q9. Is hepatitis C curable?
Yes
No
Q10. Approximately how many patients have we diagnosed as HCV RNA+ since 2018?
< 1,000
1,000-3,000
3,000-5,000
> 5,000
Q11. Approximately how many patients diagnosed with hepatitis C have attended a follow-up appointment?
< 50
200-400
400-600
> 600
Q12. What is your current role in the emergency department?
Registered Nurse
Advanced Practice Provider
Resident Physician
Attending Physician
Q13. Do you have any feedback or suggestions regarding the HCV/ HIV testing program?
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Tables
Table 1. Sample Population Demographics
Role in ED

Pre-education

Post-education

(n = 49)

(n = 48)

n (%)

n (%)

Registered nurse

31 (63.3%)

21 (43.8%)

Advanced Practice Provider

5 (10.2%)

8 (16.7%)

Resident Physician

3 (6.1%)

4 (8.3%)

Attending Physician

10 (20.4%)

15 (31.3%)

p-value

.29

Table 2: ED Staff Survey Responses
Response
options

Preeducation

Posteducation

(n = 48)

(n = 47)

Mean (SD)

Mean (SD)

p-value

HCV Knowledge Items

0-3

1.44 (0.85)

1.77 (0.81)

.057

Confidence in telling a patient that they will be
tested for HCV

1-5

3.18 (1.4)

3.83 (1.2)

.016

Perceived importance of testing UKED’s patient
population for HCV

1-3

2.67 (0.56)

2.88 (0.39)

.042

Perceived disruption in workflow when testing for
HCV

1-3

2.31 (1.05)

2.52 (0.65)

.234

Frequency of skipping HCV consent/ testing

1-5

3.42 (0.85)

2.49 (1.16)

0.36
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Table 3: Test-Ordering Frequency
Response

Pre-education

Post-education
p-value

I SOMETIMES or ALWAYS
order the test

Frequency
n = 48
n (%)

Frequency
n = 48
n (%)

28 (58%)

38 (79%)
.028

I never order the test
20 (42%)

10 (21%)

Table 4: HCV Testing & LTC Trends (Oct. 2021- March 2022)
Month

Patients
Screened

HCV Ab+

HCV Ab+
Rate

HCV RNA+

(%)

October ‘21

HCV RNA+
Rate

Linkage to
Care Rate

(%)

(%)

5,485

123

8.7%

58

45.7%

27.6%

5,382

108

8.7%

54

50.0%

45.1%

5,604

118

8.3%

53

47.7%

34.0%

5,524

102

7.8%
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38.6%

28.2%

4,707

100

8.9%

56

56.0%

16.4%

2,212

56

8.4%

29

54.7%

0.0%

days reported: 31

November ‘21
days reported: 30

December ‘21
days reported: 31

January ‘22
days reported: 31

February ‘22
days reported: 28

March ‘22
days reported:
** 12
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Figures
Figure 1: Educational Flyer (English)

Figure 2: Educational Flyer (Spanish)
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Figure 3: HCV Best Practice Advisory Actions

I never order the tests
I skip the tests if I'm too busy
I sometimes order the test based on the patient's chief complaint
I ask if the patient has had a negative test within the last year
before ordering
I order both tests after obtaining patient consent
I order both tests & do not inform patient
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